.Merck defeats revenues desires, raises purchases outlook on powerful requirement for top medicines like Keytruda CNBCMerck & Co. (MRK United States) Trumps Revenue Forecasts as Keytruda Purchases Increase BloombergMerck Supply: Pharma Titan Posts Strong Results, Yet Outlook Falls Short Investor's Company DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck trumps profit and also purchases assumptions in the middle of Keytruda strong point, however supplies mixed full-year expectation MarketWatch.